Our research indicates that by combining simple inflammatory markers, including lymphocytes, neutrophils, CRP, PCT, along with organ dysfunction, and correlating them with suspected pathogenic microorganisms in the lungs, we can effectively subgroup sCAP patients. The gene discussed is CRP; the disease is syringocystadenoma papilliferum.